FY2021 EPS Estimates for Gilead Sciences, Inc. (GILD) Raised by Analyst


Gilead Sciences, Inc. - Leerink Swann raised their FY2021 earnings per share estimates for shares of Gilead Sciences in a note issued to investors on Wednesday, September 12th. Leerink Swann analyst G. Porges now forecasts that the biopharmaceutical company will earn $6.80 per share for the year, up from their previous estimate of $6.79.



from Biotech News